INVO Bioscience, Inc. - INVO Profit before deduction of interest, taxes, depreciation and amortization
INVO Bioscience, Inc. (INVO) simplifies the fight against infertility through its INVOcell technology, which allows the embryo to develop within the mother's body. Comparing the company's EBITDA value on GURU.Markets, we see that represents the current level of this metric. However, slow adoption of the system by physicians and a capital deficit create risks. Meanwhile, operations within US clinics provide immunity to geopolitical shocks.
Summary analytical data breakdowns for INVO Bioscience (INVO)
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio INVO Bioscience, Inc.|INVO - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio INVO Bioscience Inc.|INVO - Company Aggregate Debts|Debts to Book Value INVO Bioscience|INVO - Company Long-Term Debts|Company Short-Term Indebtedness INVO Bioscience|Interim Coverage Ratio invobioscience.com
- earnings and market multiples details:
INVO - Net Profit|Future Profit INVO Bioscience, Inc.|INVO - P/E Multiple|Forward P/E Multiple INVO Bioscience Inc.|INVO - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Bioscience|INVO - Operating profit before deduction of amortization|Earnings per share for the trailing year INVO Bioscience|INVO - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months invobioscience.com|INVO - Earnings per share growth in current year|Net earnings per one share growth forecast for next year INVO Bioscience, Inc.
Summary company analytics:INVO Bioscience, Inc.
For INVO Bioscience, Inc., the current EBITDA reflects the actual cash flow from core operations, stripped of the impact of depreciation and taxes. Analyzing this metric allows for an assessment of the business transformation's efficiency as it shifts from a narrow profile to a clinic network, revealing true peaks of operational efficiency without accounting distortions, which is critical for minimizing the risks of entering at the peak of the curve.
Who INVO Bioscience, Inc. competes with
Operating income before deduction of amortization Boston Scientific Corporation Inc. (BSX)|EW: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization RMD|PODD: Operating profit EBITDA|Profit before interest, taxes and amortization Zimmer (ZBH)|COO (CooperVision) - Operating profit EBITDA|Operating profit before amortization ALGN (Align Corp)|Operating profit before deduction of amortization GMED (Globus Medical, Inc.)|TMDX (TransMedics Group, Inc.) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alphatec ATEC|AORT - Operating profit before deduction of amortization|DJO Global - Operating profit EBITDA|Profit before interest, taxes and amortization Integra LifeSciences Inc.|ESTA: Operating profit EBITDA|Operating profit before amortization BBNX|IRMD (IRADIMED) - Operating profit EBITDA|Embecta Corp (EMBC) - Operating income before deduction of amortization|Operating profit EBITDA TNDM|Operating profit before deduction of amortization Axogen Surgical AXGN|Operating profit EBITDA SIBN (SI-BONE, Inc.)|Operating profit EBITDA orthofix.com OFIX|BVS - Profit before payment of interest, taxes and amortization|KIDS: Profit before payment of interest, taxes and amortization|TMCI (Treace Medical) - Operating profit before deduction of amortization|Strata Medical - Income before deduction of interest, taxes and amortization|CARL (Carlsmed Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization rxsight.com RXST|Profit before payment of interest, taxes and amortization ClearPoint Neuro, Inc. (CLPT)|Stereotaxis Inc (STXS) - Operating profit before depreciation charges|NeuroStar - Operating profit before deduction of amortization|Operating profit EBITDA Sight Sciences Inc SGHT|Orchestra BioMed, Inc. - Operating profit EBITDA|Operating income before deduction of amortization Anika Therapeutics ANIK|InspireMD (NSPR) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ZJYL (Jin Medical)|Profit before payment of interest, taxes and amortization Vivani Medical Inc|Operating profit before deduction of amortization Xtant Medical Inc (XTNT)|Operating profit EBITDA NMTC|MODD - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Myomo MYO|COCH: Operating profit before amortization|VVOS: Operating profit before deduction of amortization|enVVeno Corp - Company profit before taxes, interest and amortization|SINT: Operating profit EBITDA|TNON - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Lifeward|Operating profit before amortization AMIX (Autonomix)|Operating profit before deduction of amortization IVF (INVO Bioscience, Inc.)|Profit before payment of interest, taxes and amortization BBLG (Bone Biologics Inc)|Profit before payment of interest, taxes and amortization Axonics, Inc. AXNX|biolase.com (BIOL) - Profit before interest, taxes and amortization|DYNT: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization FNA (Paragon 28, Inc.)
